Literature DB >> 19811778

T lineage differentiation from induced pluripotent stem cells.

Fengyang Lei1, Rizwanul Haque, Lauren Weiler, Kent E Vrana, Jianxun Song.   

Abstract

Induced pluripotent stem (iPS) cells have potential to differentiate into T lymphocytes, however, the actual ability of iPS cells to develop into T lineages is not clear. In this study, we co-cultured iPS cells on OP9 cells expressing the Notch ligand Delta-like 1 (DL1), the iPS cells differentiated into T lymphocytes. In addition, in vitro stimulation of iPS cell-derived T lymphocytes resulted in secretion of IL-2 and IFN-gamma. Moreover, adoptive transfer of iPS cell-derived T lymphocytes into Rag-deficient mice reconstituted their T cell pools. These results indicate that iPS cells are able to follow the normal program of T cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19811778     DOI: 10.1016/j.cellimm.2009.09.005

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  25 in total

1.  Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies.

Authors:  Itai M Pessach; Jose Ordovas-Montanes; Shen-Ying Zhang; Jean-Laurent Casanova; Silvia Giliani; Andrew R Gennery; Waleed Al-Herz; Philip D Manos; Thorsten M Schlaeger; In-Hyun Park; Francesca Rucci; Suneet Agarwal; Gustavo Mostoslavsky; George Q Daley; Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2010-12-24       Impact factor: 10.793

Review 2.  Induced pluripotent stem cell (iPSCs) and their application in immunotherapy.

Authors:  Zhengping Jiang; Yanmei Han; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2013-12-16       Impact factor: 11.530

Review 3.  Paths to stemness: building the ultimate antitumour T cell.

Authors:  Luca Gattinoni; Christopher A Klebanoff; Nicholas P Restifo
Journal:  Nat Rev Cancer       Date:  2012-09-21       Impact factor: 60.716

4.  Programming of regulatory T cells from pluripotent stem cells and prevention of autoimmunity.

Authors:  Rizwanul Haque; Fengyang Lei; Xiaofang Xiong; Yanqing Bian; Baohua Zhao; Yuzhang Wu; Jianxun Song
Journal:  J Immunol       Date:  2012-06-25       Impact factor: 5.422

Review 5.  Mesodermal and hematopoietic differentiation from ES and iPS cells.

Authors:  Tomoko Inoue-Yokoo; Kenzaburo Tani; Daisuke Sugiyama
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

6.  In Vitro Differentiation of T Cells from Murine Pluripotent Stem Cells.

Authors:  Xiaoniao Chen; Fengyang Lei; Liqiang Wang; Xiaofang Xiong; Jianxun Song
Journal:  Methods Mol Biol       Date:  2019

Review 7.  Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 8.  Targeting Stem Cell-Derived Tissue-Associated Regulatory T Cells for Type 1 Diabetes Immunotherapy.

Authors:  Mohammad Haque; Jugal Kishore Das; Xiaofang Xiong; Jianxun Song
Journal:  Curr Diab Rep       Date:  2019-08-30       Impact factor: 4.810

Review 9.  In Vitro T-Cell Generation From Adult, Embryonic, and Induced Pluripotent Stem Cells: Many Roads to One Destination.

Authors:  Michelle J Smith; Beau R Webber; Mahmood Mohtashami; Heather E Stefanski; Juan Carlos Zúñiga-Pflücker; Bruce R Blazar
Journal:  Stem Cells       Date:  2015-08-11       Impact factor: 6.277

10.  Melanoma Immunotherapy in Mice Using Genetically Engineered Pluripotent Stem Cells.

Authors:  Mohammad Haque; Jianyong Song; Kristin Fino; Praneet Sandhu; Youfei Wang; Bing Ni; Deyu Fang; Jianxun Song
Journal:  Cell Transplant       Date:  2016-01-15       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.